Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors

This publication has 16 references indexed in Scilit:

• Transcriptional regulation via the NF-κB signaling module
  Oncogene, 2006
• The alternative NF-κB pathway from biochemistry to biology: Pitfalls and promises for future drug development
  Biochemical Pharmacology, 2006
• Small molecule inhibitors of IKK kinase activity
  Expert Opinion on Therapeutic Patents, 2005
• Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides
  Bioorganic & Medicinal Chemistry Letters, 2005
• IκB kinases: key regulators of the NF-κB pathway
  Trends in Biochemical Sciences, 2004
• The IKK NF-κB system: a treasure trove for drug development
  Nature Reviews Drug Discovery, 2004
• Anti-TNF-α therapies: the next generation
  Nature Reviews Drug Discovery, 2003
• BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice
  Journal of Biological Chemistry, 2003
• NF-κB Regulation by IκB Kinase-2 in Rheumatoid Arthritis Synoviocytes
  The Journal of Immunology, 2001
• Peptides Corresponding to the N and C Termini of IκB-α, -β, and -ε as Probes of the Two Catalytic Subunits of IκB Kinase, IKK-1 and IKK-2
  Journal of Biological Chemistry, 1999